IR: Establishing U.S. Presence for Series A

Origenis logo

Origenis Establishes and Consolidates Presence in U.S. Investor Community

  • Establish company presence among U.S. investors and raise fund in the U.S. for a European central nervous system biotechnology company 
  • Created messages and revised corporate presentation (LHS Immersion®) 
  • Identified and conducted outreach to targeted U.S. investors and high value partners 
  • Organized and facilitated investor meetings at BIO Investor Forum, Bio-Europe, Biotech Showcase, Sachs Forums, and non-deal roadshow on the east coast 
  • Provided strategic counseling on Series A fundraising in the U.S. 
  • Introduced company to approximately 500 U.S. investors 
  • Initiated and managed more than 40 investor meetings both on site and via telecon 
  • Conducted substantial conversations with 7 investment firms under confidential disclosure agreement 
  • Currently in the process of finalizing a syndicate